11-17552085-A-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001292063.2(OTOG):​c.292+10A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.018 in 1,549,972 control chromosomes in the GnomAD database, including 300 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 28 hom., cov: 33)
Exomes 𝑓: 0.018 ( 272 hom. )

Consequence

OTOG
NM_001292063.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.72

Publications

1 publications found
Variant links:
Genes affected
OTOG (HGNC:8516): (otogelin) The protein encoded by this gene is a component of the acellular membranes of the inner ear. Disruption of the orthologous mouse gene shows that it plays a role in auditory and vestibular functions. It is involved in fibrillar network organization, the anchoring of otoconial membranes and cupulae to the neuroepithelia, and likely in sound stimulation resistance. Mutations in this gene cause autosomal recessive nonsyndromic deafness, type 18B. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]
OTOG Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 18B
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine, Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 11-17552085-A-T is Benign according to our data. Variant chr11-17552085-A-T is described in ClinVar as Benign. ClinVar VariationId is 226881.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0144 (2186/152246) while in subpopulation NFE AF = 0.0205 (1395/67986). AF 95% confidence interval is 0.0196. There are 28 homozygotes in GnomAd4. There are 1099 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 28 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTOGNM_001292063.2 linkc.292+10A>T intron_variant Intron 4 of 55 ENST00000399397.6 NP_001278992.1 H9KVB3
OTOGNM_001277269.2 linkc.328+10A>T intron_variant Intron 3 of 54 NP_001264198.1 Q6ZRI0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTOGENST00000399397.6 linkc.292+10A>T intron_variant Intron 4 of 55 5 NM_001292063.2 ENSP00000382329.2 H9KVB3
OTOGENST00000399391.7 linkc.328+10A>T intron_variant Intron 3 of 54 5 ENSP00000382323.2 Q6ZRI0-1
OTOGENST00000428619.1 linkc.109+10A>T intron_variant Intron 2 of 3 3 ENSP00000399057.2 C9IZ84
OTOGENST00000498332.5 linkn.198+10A>T intron_variant Intron 3 of 15 5

Frequencies

GnomAD3 genomes
AF:
0.0144
AC:
2188
AN:
152128
Hom.:
28
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00415
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0140
Gnomad ASJ
AF:
0.0159
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00518
Gnomad FIN
AF:
0.0271
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0205
Gnomad OTH
AF:
0.0158
GnomAD2 exomes
AF:
0.0140
AC:
2086
AN:
149136
AF XY:
0.0137
show subpopulations
Gnomad AFR exome
AF:
0.00308
Gnomad AMR exome
AF:
0.00965
Gnomad ASJ exome
AF:
0.0188
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0242
Gnomad NFE exome
AF:
0.0194
Gnomad OTH exome
AF:
0.0165
GnomAD4 exome
AF:
0.0184
AC:
25670
AN:
1397726
Hom.:
272
Cov.:
30
AF XY:
0.0180
AC XY:
12408
AN XY:
689452
show subpopulations
African (AFR)
AF:
0.00301
AC:
95
AN:
31594
American (AMR)
AF:
0.0106
AC:
378
AN:
35686
Ashkenazi Jewish (ASJ)
AF:
0.0191
AC:
482
AN:
25178
East Asian (EAS)
AF:
0.0000560
AC:
2
AN:
35734
South Asian (SAS)
AF:
0.00583
AC:
462
AN:
79230
European-Finnish (FIN)
AF:
0.0232
AC:
1118
AN:
48198
Middle Eastern (MID)
AF:
0.00878
AC:
50
AN:
5692
European-Non Finnish (NFE)
AF:
0.0206
AC:
22250
AN:
1078444
Other (OTH)
AF:
0.0144
AC:
833
AN:
57970
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
1157
2314
3471
4628
5785
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
866
1732
2598
3464
4330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0144
AC:
2186
AN:
152246
Hom.:
28
Cov.:
33
AF XY:
0.0148
AC XY:
1099
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.00414
AC:
172
AN:
41546
American (AMR)
AF:
0.0140
AC:
214
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0159
AC:
55
AN:
3470
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5182
South Asian (SAS)
AF:
0.00519
AC:
25
AN:
4818
European-Finnish (FIN)
AF:
0.0271
AC:
288
AN:
10620
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0205
AC:
1395
AN:
67986
Other (OTH)
AF:
0.0156
AC:
33
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
118
235
353
470
588
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0159
Hom.:
6
Bravo
AF:
0.0132
Asia WGS
AF:
0.00404
AC:
14
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 25, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

328+10A>T in intron 3 of OTOG: This variant is not expected to have clinical sig nificance because it is not located within the conserved splice consensus sequen ce. It has been identified in 4.2% (5/120) of Colombian chromosomes from a broad population by the 1000 Genomes Project (http://www.ncbi.nlm.nih.gov/projects/SN P; dbSNP rs141597314). -

Jul 09, 2020
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
5.3
DANN
Benign
0.68
PhyloP100
-1.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141597314; hg19: chr11-17573632; API